Last updated on March 2019

A Study to Evaluate the Safety and Efficacy of AJM300 in Participants With Active Ulcerative Colitis


Brief description of study

The study will investigate the efficacy and safety of an oral dose of AJM300 960 milligram (mg)/dose administered three times daily for 8 weeks in participants with active ulcerative colitis.

Clinical Study Identifier: NCT03531892

Contact Investigators or Research Sites near you

Start Over

Public Relations Group

AJM300/CT3 trial site 9
Toyoake, Japan
  Connect »

Public Relations Group

AJM300/CT3 trial site 11
Kashiwa, Japan
  Connect »

Public Relations Group

AJM300/CT3 trial site 2
Sapporo, Japan
  Connect »

Public Relations Group

AJM300/CT3 trial site 3
Sapporo, Japan
  Connect »

Public Relations Group

AJM300/CT3 trial site 4
Sapporo, Japan
  Connect »

Public Relations Group

AJM300/CT3 trial site 16
Takamatsu, Japan
  Connect »

Public Relations Group

AJM300/CT3 trial site 12
Kamakura, Japan
  Connect »

Public Relations Group

AJM300/CT3 trial site 13
Yokohama, Japan
  Connect »

Public Relations Group

AJM300/CT3 trial site 6
Yokohama, Japan
  Connect »

Public Relations Group

AJM300/CT3 trial site 15
Kurashiki, Japan
  Connect »

Public Relations Group

AJM300/CT3 trial site 10
Takatsuki, Japan
  Connect »

Public Relations Group

AJM300/CT3 trial site 5
Ageo, Japan
  Connect »

Public Relations Group

AJM300/CT3 trial site 17
Hamamatsu, Japan
  Connect »

Public Relations Group

AJM300/CT3 trial site 41
Nagoya, Japan
  Connect »

Public Relations Group

AJM300/CT3 trial site 33
Toyohashi, Japan
  Connect »

Public Relations Group

AJM300/CT3 trial site 42
Toyota, Japan
  Connect »

Public Relations Group

AJM300/CT3 trial site 39
Hirosaki, Japan
  Connect »

Public Relations Group

AJM300/CT3 trial site 24
Tikushino, Japan
  Connect »

Public Relations Group

AJM300/CT3 trial site 35
Fukuyama, Japan
  Connect »

Public Relations Group

AJM300/CT3 trial site 18
Asahikawa, Japan
  Connect »

Public Relations Group

AJM300/CT3 trial site 26
Asahikawa, Japan
  Connect »

Public Relations Group

AJM300/CT3 trial site 34
Kobe, Japan
  Connect »

Public Relations Group

AJM300/CT3 trial site 19
Morioka, Japan
  Connect »

Public Relations Group

AJM300/CT3 trial site 32
Sagamihara, Japan
  Connect »

Public Relations Group

AJM300/CT3 trial site 22
Nagaoka, Japan
  Connect »

Public Relations Group

AJM300/CT3 trial site 40
Ageo, Japan
  Connect »

Public Relations Group

AJM300/CT3 trial site 29
Shimotsuga, Japan
  Connect »

Public Relations Group

AJM300/CT3 trial site 30
Chuo, Japan
  Connect »

Public Relations Group

AJM300/CT3 trial site 31
Hachioji, Japan
  Connect »

Public Relations Group

AJM300/CT3 trial site 38
Shinagawa, Japan
  Connect »

Public Relations Group

AJM300/CT3 trial site 21
Shinjuku, Japan
  Connect »

Public Relations Group

AJM300/CT3 trial site 57
Nagoya, Japan
  Connect »

Public Relations Group

AJM300/CT3 trial site 49
Hirosaki, Japan
  Connect »

Public Relations Group

AJM300/CT3 trial site 51
Kashiwa, Japan
  Connect »

Public Relations Group

AJM300/CT3 trial site 54
Urayasu, Japan
  Connect »

Public Relations Group

AJM300/CT3 trial site 53
Kurume, Japan
  Connect »

Public Relations Group

AJM300/CT3 trial site 55
Isesaki, Japan
  Connect »

Public Relations Group

AJM300/CT3 trial site 14
Sagamihara, Japan
  Connect »

Public Relations Group

AJM300/CT3 trial site 47
Tsu, Japan
  Connect »

Public Relations Group

AJM300/CT3 trial site 46
Yokkaichi, Japan
  Connect »

Public Relations Group

AJM300/CT3 trial site 45
Sendai, Japan
  Connect »

Public Relations Group

AJM300/CT3 trial site 50
Sendai, Japan
  Connect »

Public Relations Group

AJM300/CT3 trial site 60
Ashikaga, Japan
  Connect »

Public Relations Group

AJM300/CT3 trial site 61
Bunkyo, Japan
  Connect »

Public Relations Group

AJM300/CT3 trial site 59
Chiyoda, Japan
  Connect »

Public Relations Group

AJM300/CT3 trial site 56
Minato, Japan
  Connect »

Public Relations Group

AJM300/CT3 trial site 52
Shinjuku, Japan
  Connect »

Public Relations Group

AJM300/CT3 trial site 63
Nagoya, Japan
  Connect »

Public Relations Group

AJM300/CT3 trial site 64
Nishinomiya, Japan
  Connect »

Public Relations Group

AJM300/CT3 trial site 68
Bunkyo, Japan
  Connect »

Public Relations Group

AJM300/CT3 trial site 66
Minato, Japan
  Connect »

Public Relations Group

AJM300/CT3 trial site 70
Kurashiki, Japan
  Connect »

Public Relations Group

AJM300/CT3 trial site 72
Tokorozawa, Japan
  Connect »

Public Relations Group

AJM300/CT3 trial site 71
Utsunomiya, Japan
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.